Stock listing
Frankfurt:94E Zura Bio Limited Aktie
German listing (Frankfurt) of Zura Bio Limited · home listing NASDAQ:ZURA
Follow Zura Bio Limited into a list and get an email when it puts out news.
Share price · FWB:94E
€3.30 EUR -0.22 (-6.1%)
Close on Nov 6, 2026
- Day range
- €3.30 – €3.30 EURNov 6, 2026
- Market cap
- €315.9M EURAt the close on Nov 6, 2026 · price × 95.83M shares outstanding
- Traded on an average day
- €6,735 EURMedian day 0 shares · 41 days with no trades · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZURA · Home | $4.09 USD | +0.37 (+9.9%) | 3,001,495 | $3.80 | $4.245 | $3.76 | $3.72 | Close on Nov 6, 2026 |
| Frankfurt:94E | €3.296 EUR | -0.215 (-6.1%) | — | €3.296 | €3.296 | €3.296 | €3.511 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · FWB:94E · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €3.296 | -0.215 | -6.1% | €3.296 | €3.296 | €3.296 | 0 | |
| €3.511 | -0.006 | -0.2% | €3.511 | €3.511 | €3.511 | 1,000 | |
| €3.517 | +0.008 | +0.2% | €3.517 | €3.517 | €3.517 | 1,000 | |
| €3.509 | -0.112 | -3.1% | €3.509 | €3.509 | €3.509 | 1,680 | |
| €3.621 | +0.241 | +7.1% | €3.621 | €3.621 | €3.621 | 0 | |
| €3.38 | -0.419 | -11.0% | €3.38 | €3.38 | €3.38 | 4,640 | |
| €3.799 | +0.168 | +4.6% | €3.799 | €3.799 | €3.799 | 500 | |
| €3.631 | +0.466 | +14.7% | €3.631 | €3.631 | €3.631 | 608 | |
| €3.165 | +0.213 | +7.2% | €3.165 | €3.165 | €3.165 | 0 | |
| €2.952 | -0.292 | -9.0% | €2.952 | €2.952 | €2.952 | 70,400 | |
| €3.244 | -0.372 | -10.3% | €3.244 | €3.244 | €3.244 | 7,800 | |
| €3.616 | +0.074 | +2.1% | €3.616 | €3.616 | €3.616 | 0 | |
| €3.542 | +0.188 | +5.6% | €3.542 | €3.542 | €3.542 | 0 | |
| €3.354 | -0.127 | -3.6% | €3.354 | €3.354 | €3.354 | 0 | |
| €3.481 | -0.31 | -8.2% | €3.481 | €3.481 | €3.481 | 0 | |
| €3.791 | -0.092 | -2.4% | €3.791 | €3.791 | €3.791 | 0 | |
| €3.883 | -0.129 | -3.2% | €3.883 | €3.883 | €3.883 | 0 | |
| €4.012 | +0.23 | +6.1% | €3.812 | €4.022 | €3.76 | 2,000 | |
| €3.782 | +0.247 | +7.0% | €3.511 | €3.802 | €3.499 | 2,000 | |
| €3.535 | -0.083 | -2.3% | €3.535 | €3.535 | €3.535 | 1,200 | |
| €3.618 | -0.063 | -1.7% | €3.618 | €3.618 | €3.618 | 1,700 | |
| €3.681 | +0.229 | +6.6% | €3.681 | €3.681 | €3.681 | 2,770 | |
| €3.452 | -0.034 | -1.0% | €3.452 | €3.452 | €3.452 | 0 | |
| €3.486 | -0.125 | -3.5% | €3.486 | €3.486 | €3.486 | 0 | |
| €3.611 | -0.027 | -0.7% | €3.611 | €3.611 | €3.611 | 0 | |
| €3.638 | -0.01 | -0.3% | €3.638 | €3.638 | €3.637 | 242 | |
| €3.648 | +0.179 | +5.2% | €3.648 | €3.648 | €3.648 | 0 | |
| €3.469 | -0.106 | -3.0% | €3.469 | €3.469 | €3.469 | 0 | |
| €3.575 | +0.09 | +2.6% | €3.575 | €3.575 | €3.575 | 0 | |
| €3.485 | -0.129 | -3.6% | €3.485 | €3.485 | €3.485 | 0 | |
| €3.614 | -0.111 | -3.0% | €3.614 | €3.614 | €3.614 | 756 | |
| €3.725 | -0.152 | -3.9% | €3.725 | €3.725 | €3.725 | 0 | |
| €3.877 | -0.025 | -0.6% | €3.877 | €3.877 | €3.877 | 0 | |
| €3.902 | +0.061 | +1.6% | €3.902 | €3.902 | €3.902 | 0 | |
| €3.841 | -0.088 | -2.2% | €3.841 | €3.841 | €3.841 | 0 | |
| €3.929 | -0.047 | -1.2% | €3.929 | €3.929 | €3.929 | 3,078 | |
| €3.976 | -0.251 | -5.9% | €3.976 | €3.976 | €3.976 | 0 | |
| €4.227 | -0.225 | -5.1% | €4.227 | €4.227 | €4.227 | 0 | |
| €4.452 | -0.007 | -0.2% | €4.452 | €4.452 | €4.452 | 0 | |
| €4.459 | -0.083 | -1.8% | €4.459 | €4.459 | €4.459 | 0 | |
| €4.542 | -0.319 | -6.6% | €4.542 | €4.542 | €4.542 | 864 | |
| €4.861 | -0.09 | -1.8% | €4.861 | €4.861 | €4.861 | 0 | |
| €4.951 | -0.342 | -6.5% | €5.203 | €5.252 | €4.946 | 1,304 | |
| €5.293 | +0.007 | +0.1% | €5.293 | €5.293 | €5.293 | 4,000 | |
| €5.286 | +0.286 | +5.7% | €5.286 | €5.286 | €5.286 | 0 | |
| €5.00 | +0.148 | +3.1% | €5.00 | €5.00 | €5.00 | 0 | |
| €4.852 | +0.067 | +1.4% | €4.852 | €4.852 | €4.852 | 0 | |
| €4.785 | +0.09 | +1.9% | €4.785 | €4.785 | €4.785 | 0 | |
| €4.695 | -0.17 | -3.5% | €4.695 | €4.695 | €4.695 | 0 | |
| €4.865 | -0.185 | -3.7% | €4.865 | €4.865 | €4.865 | 1,424 | |
| €5.05 | -0.095 | -1.8% | €5.05 | €5.05 | €5.05 | 11,244 | |
| €5.145 | -0.198 | -3.7% | €5.145 | €5.145 | €5.145 | 778 | |
| €5.343 | -0.065 | -1.2% | €5.343 | €5.343 | €5.343 | 0 | |
| €5.408 | +0.477 | +9.7% | €5.408 | €5.408 | €5.408 | 5,404 | |
| €4.931 | +0.103 | +2.1% | €4.931 | €4.931 | €4.931 | 260 | |
| €4.828 | -0.152 | -3.1% | €4.828 | €4.828 | €4.828 | 0 | |
| €4.98 | +0.021 | +0.4% | €4.98 | €4.98 | €4.98 | 0 | |
| €4.959 | +0.176 | +3.7% | €4.959 | €4.959 | €4.959 | 0 | |
| €4.783 | -0.005 | -0.1% | €4.783 | €4.783 | €4.783 | 0 | |
| €4.788 | -0.047 | -1.0% | €4.788 | €4.788 | €4.788 | 0 | |
| €4.835 | -0.156 | -3.1% | €4.835 | €4.835 | €4.835 | 0 | |
| €4.991 | +0.219 | +4.6% | €4.991 | €4.991 | €4.991 | 0 | |
| €4.772 | -0.039 | -0.8% | €4.772 | €4.772 | €4.772 | 0 | |
| €4.811 | -0.318 | -6.2% | €4.811 | €4.811 | €4.811 | 0 | |
| €5.129 | +0.251 | +5.1% | €5.129 | €5.129 | €5.129 | 0 | |
| €4.878 | +0.065 | +1.4% | €4.878 | €4.878 | €4.878 | 210 | |
| €4.813 | -0.08 | -1.6% | €4.813 | €4.813 | €4.813 | 562 |
- Ticker
- Frankfurt:94E
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Frankfurt
- Currency
- EUR
What changed lately
Latest news release · Nov 9, 2026
Zura Bio Provides Clinical Update on Phase 2 TibuSHIELD Study of Tibulizumab (ZB-106) in Hidradenitis Suppurativa
Latest deck · Oct 27, 2026
Investor Presentation (October 2026)
Investor deck · 51 slides
Latest news
Zura Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 27, 2026
Closed €3.63 (+14.7%) on Oct 28, 2026
Zura Bio Reports Third Quarter 2026 Financial Results and Recent Corporate Updates
Oct 27, 2026
Closed €3.17 (+7.2%) on Oct 27, 2026
Zura Bio to Participate in the Cantor Global Healthcare Conference
Aug 31, 2026
Closed €4.70 (-3.5%) on Sep 1, 2026
Zura Bio Reports Second Quarter 2026 Financial Results and Recent Corporate Updates
Aug 11, 2026
Closed €4.81 (-6.2%) on Aug 11, 2026
Zura Bio Exceeds Enrollment Target in Both Hidradenitis Suppurativa (HS) & Systemic Sclerosis (SSc) Phase 2 Studies and Expands Tibulizumab Program
Jun 29, 2026
Closed €4.69 (+18.8%) on Jun 29, 2026
Zura Bio Expands Leadership Team with Appointment of Muzammil Mustufa as Chief Business Officer
May 13, 2026
Closed €3.99 (+1.1%) on May 13, 2026
Zura Bio Reports First Quarter 2026 Financial Results and Recent Corporate Updates
May 7, 2026
Closed €4.11 (-6.0%) on May 7, 2026
Zura Bio Reports Full Year 2025 Financial Results and Recent Corporate Updates
Mar 19, 2026
Closed €5.08 (-7.8%) on Mar 19, 2026
Financings
Public offering of class A ordinary shares and pre-funded warrants
Feb 27, 2026
Closed: US$144M raised · US$6.25 a share · Leerink Partners +3
Dealers: Leerink Partners (co-lead), Piper Sandler (co-lead), Cantor (co-lead), Wedbush PacGrow
Announced Feb 24, 2026 · Update Feb 25, 2026 · Closed Feb 27, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 51 slides · Oct 27, 2026
Investor Presentation (August 2026)
Investor deck · 50 slides · Aug 11, 2026
Investor Presentation (August 2026)
Investor deck · 51 slides · August 2026
Investor Presentation (July 2026)
Investor deck · 31 slides · Jul 1, 2026
Zura Bio Limited on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 20 in the last 12 months · 54 in all · newest Nov 9, 2026 · oldest 2023
- Decks
- 23 decks · latest Oct 27, 2026
Where Zura Bio Limited is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZURA · Home listing | NASDAQ | United States | USD |
| Frankfurt:94E · This page | Frankfurt | Germany | EUR |
| Stuttgart:94E | Stuttgart | Germany | EUR |
| BOATS:ZURA | BOATS | United States | USD |
| Dusseldorf:94E | Dusseldorf | Germany | EUR |
| Tradegate:94E | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Zura Bio Limited.